B. Delatour et al., FE65 in Alzheimer's disease - Neuronal distribution and association with neurofibrillary tangles, AM J PATH, 158(5), 2001, pp. 1585-1591
Citations number
31
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
FE65, a protein expressed in the nervous system, has the ability to bind th
e C-terminal domain of the amyloid precursor protein. This suggests a role
for FE65 in the pathogenesis of Alzheimer's disease (AD), The present study
mas conducted to find out if the distribution of FE65 immunoreactivity was
affected during the course of AD, and to determine the degree of co-locali
zation of FE65 with other proteins known to be involved in AD. Single immun
operoxidase-labeling experiments, conducted on six sporadic AD patients and
six nondemented age-matched controls, showed that the proportion of volume
occupied by FE65 immunoreactivity was not modified in the isocortex of AD
patients. However, in hippocampal area CA4, increased FE65 immunoreactivity
seemed to be associated with the severity of the disease. Double-immunoflu
orescent labeling did not show any clear co-localization of FE65 with the a
myloid precursor protein. FE65 immunoreactivity was also absent from focal
and diffuse deposits of the P-amyloid peptide. Unexpectedly double labeling
experiments showed a co-localization of FE65 and tau proteins in intracell
ular tangles. Ultrastructural observations confirmed that FE65 was associat
ed with paired helical filaments.